This program project is designed to investigate the mechanism and role of hyperglycemia and hyperinsulinemia in explaining the excess risk of cardiovascular disease in people with diabetes. The program provides a multidisciplinary and innovative approach to address the biochemical molecular and genetic factors involved in cardiovascular disease in diabetes. One hypothesis is that accelerated lipid pathways including lipoxygenases provide a link between hyperglycemia, oxidative stress and inflammatory vessel wall changes. The other hypothesis is that specific genetic factors associated with hyperinsulinemia play a major role in coronary artery disease development in people with NIDDM. Project 1 will utilize in vitro and in vivo approaches to evaluate the role of LO enzymes in mediating fatty streak development in diabetes. Project 2 will evaluate the role of LO enzymes and novel species of phosphatidic acid mediating cytokine and growth factor action on vascular smooth muscle cells. Project 3 will involve the characterization of a unique swine model of accelerated atherosclerosis in NIDDM. This model shows """"""""humanoid"""""""" features including hypertriglyceridemia and vascular calcification. This model will be utilized to evaluate the in vivo relevance of pathways in projects #1 and #2 and determine the effects of insulin and other therapeutic modalities on atherosclerosis development. Project #4 will combine a unique genetic study in Hispanic families in which the proband has NIDDM. Two groups of families will be studied, one with and one without documented coronary disease in order to determine the genetic factors linked to either development of or protection from coronary disease in the presence of insulin resistance. Clearly, each project has its own scientific merit and focus, however, combined there is a much greater likelihood of increasing our understanding of the features leading to diabetic macrovascular disease and a more rapid translation of this information to new pharmacologic or molecular approaches to reduce this major cause of morbidity and mortality in this country.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Program Projects (P01)
Project #
1P01HL055798-01
Application #
2234431
Study Section
Special Emphasis Panel (ZHL1-CCT-L (S1))
Project Start
1995-09-30
Project End
2000-07-31
Budget Start
1995-09-30
Budget End
1996-07-31
Support Year
1
Fiscal Year
1995
Total Cost
Indirect Cost
Name
City of Hope National Medical Center
Department
Type
DUNS #
City
Duarte
State
CA
Country
United States
Zip Code
91010
Jeong, Se-Jin; Kim, Sinai; Park, Jong-Gil et al. (2018) Prdx1 (peroxiredoxin 1) deficiency reduces cholesterol efflux via impaired macrophage lipophagic flux. Autophagy 14:120-133
Gao, Chuan; Tabb, Keri L; Dimitrov, Latchezar M et al. (2018) Exome Sequencing Identifies Genetic Variants Associated with Circulating Lipid Levels in Mexican Americans: The Insulin Resistance Atherosclerosis Family Study (IRASFS). Sci Rep 8:5603
Gaddis, Dalia E; Padgett, Lindsey E; Wu, Runpei et al. (2018) Apolipoprotein AI prevents regulatory to follicular helper T cell switching during atherosclerosis. Nat Commun 9:1095
Que, Xuchu; Hung, Ming-Yow; Yeang, Calvin et al. (2018) Oxidized phospholipids are proinflammatory and proatherogenic in hypercholesterolaemic mice. Nature 558:301-306
Senders, Max L; Que, Xuchu; Cho, Young Seok et al. (2018) PET/MR Imaging of Malondialdehyde-Acetaldehyde Epitopes With a Human Antibody Detects Clinically Relevant Atherothrombosis. J Am Coll Cardiol 71:321-335
Byun, Young Sup; Yang, Xiaohong; Bao, Weihang et al. (2017) Oxidized Phospholipids on Apolipoprotein B-100 and Recurrent Ischemic Events Following Stroke or Transient Ischemic Attack. J Am Coll Cardiol 69:147-158
Torzewski, Michael; Ravandi, Amir; Yeang, Calvin et al. (2017) Lipoprotein(a) Associated Molecules are Prominent Components in Plasma and Valve Leaflets in Calcific Aortic Valve Stenosis. JACC Basic Transl Sci 2:229-240
Moriarty, Patrick M; Varvel, Stephen A; Gordts, Philip L S M et al. (2017) Lipoprotein(a) Mass Levels Increase Significantly According to APOE Genotype: An Analysis of 431?239 Patients. Arterioscler Thromb Vasc Biol 37:580-588
Yeang, Calvin; Gordts, Philip L S M; Tsimikas, Sotirios (2017) Novel Lipoprotein(a) Catabolism Pathway via Apolipoprotein(a) Recycling: Adding the Plasminogen Receptor PlgRKT to the List. Circ Res 120:1050-1052
Ley, Klaus; Gerdes, Norbert; Winkels, Holger (2017) ATVB Distinguished Scientist Award: How Costimulatory and Coinhibitory Pathways Shape Atherosclerosis. Arterioscler Thromb Vasc Biol 37:764-777

Showing the most recent 10 out of 217 publications